Grahn, Alexandra
Coleman, Jonathan A.
Eriksson, Ylva
Gabrielsson, Susanne
Madsen, Jonna Skov
Tham, Emma
Thomas, Kay
Turney, Ben
Uhlén, Per
Vollmer, Tino
Zieger, Karsten
Osther, Palle Jörn Sloth
Brehmer, Marianne http://orcid.org/0000-0001-9232-363X
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 31 March 2023
Accepted: 23 August 2023
First Online: 19 September 2023
Declarations
:
: Grahn: None. Eriksson: None. Gabrielsson: Scientific Advisory Board, Anjarium Biosciences and patent granted for Exosomes for targeting B-cells for therapy. Skov Madsen: None. Tham: None. Thomas: None. Uhlén: None. Vollmer: None. Zieger: None. Osther: Consultation for Olympus, speaker for Coloplast, Boston Scientific, Olympus. Brehmer: Consultation for Boston Scientific.
: This is a review article involving no studies on human participants and/or animals. Informed consent is not relevant.